HYEX · Healthy Extracts Inc.
$1.17
-0.07 (-5.61%)
At close · Aug 25
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to its neutral cash flow, the Company has doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued. In addition, most of the Company's development activities since inception have been financially sustained through equity financing but it is using all additional cash flow to help support the Company's growth and research and development of new products. Management plans to keep seeking funding through debt and equity financing which are intended to mitigate the conditions that have raise substantial doubt about the entity's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$17.25M
Shares
14.74M
HYEX metrics
49 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$1.17
Market cap
$17.25M
Price action
19 metricsPrice change (1W)
-13.3%
Price change (30D)
-15.7%
Price change (3M)
+3.5%
Price change (6M)
-50.2%
Price change (YTD)
-23.0%
Price change (1Y)
-64.8%
Trailing year
Price change (5Y)
—
52-week high
$3.35
52-week low
$0.84
Change from 52-week high
-65.1%
Change from 52-week low
+38.7%
Annualized volatility
293.6%
Beta
2.0
RSI (14D)
44.2
Price vs SMA 50
-21.9%
Price vs SMA 200
-43.4%
Avg volume (3M)
762
Relative volume
0.1
Average dollar volume
$1,201
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
14.74M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.7×
reciprocal yield 36.5%
P / book
0.8
reciprocal yield 130.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
34.5
reciprocal yield 2.9%
Earnings yield
-5.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
61.1%
Operating margin
—
Trailing 12 months
Net margin
-14.0%
Gross profit (TTM)
$3.85M
Operating profit (TTM)
—
Net income (TTM)
−$879,358
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+113.4%
Year over year
Net income growth YoY
-292.8%
Revenue (TTM)
$6.29M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+47.9%
Year over year · more shares
Revenue CAGR (3Y)
+26.1%
Revenue CAGR (5Y)
+28.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-3.9%
Return on assets
-2.7%
Debt / equity
—
Current ratio
0.2
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$189,958
Latest balance sheet
Cash & equivalents
$189,958
Total assets
$32.61M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$500,267
Capital expenditures (TTM)
$0
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$0
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged